The founder and former top employees of a pharmaceutical company are facing a reckoning for their role in a bribery scheme that prosecutors say boosted sales of a powerful, highly addictive painkiller and helped fuel the national opioid epidemic. Starting Monday, seven people who worked ...
Melania Trump was widely booed when she took the stage at a youth event in Baltimore on Tuesday, an unusually hostile reception for a U.S. first lady. The sustained boos, which bookended her remarks and were interrupted by some cheers, marked the latest negative reception ...
China jails nine fentanyl smugglers in first joint case with U.S.
A Chinese court on Thursday imprisoned nine people, one whom got a suspended death sentence, on charges of smuggling fentanyl into the United States, in the first such case the two countries had worked on together. China has faced U.S. criticism for not doing enough ...
Drug companies near $260 million deal to settle U.S. lawsuit over opioid crisis
Three leading American drug distributors and an Israeli drugmaker blamed for a deadly U.S. opioid epidemic settled a bellwether civil lawsuit with two Ohio counties Monday, opening the door for a broader national settlement worth billions of dollars. The $260 million deal with Ohio's Summit ...
Complicity, opioids and vaping — a bad mix
After deluge of lawsuits, OxyContin maker Purdue Pharma files for bankruptcy protection
OxyContin maker Purdue Pharma LP filed for bankruptcy protection Sunday night, succumbing to pressure from more than 2,600 lawsuits alleging the company helped fuel the deadly U.S. opioid epidemic. Purdue's board met Sunday evening to approve the long-expected bankruptcy filing, which the company is pursuing ...
OxyContin maker Purdue Pharma LP reached a tentative agreement with some plaintiffs to resolve widespread litigation over its alleged role in fueling the U.S. opioid crisis and plans to tussle with states opposing its settlement offer in bankruptcy proceedings starting as soon as next ...
OxyContin maker Purdue prepares 'free-fall' bankruptcy as settlement talks stall, sources say
OxyContin maker Purdue Pharma LP is preparing to seek bankruptcy protection before the end of the month if it does not reach a settlement with U.S. communities over widespread opioid litigation, three people familiar with the matter said, after some states balked at the ...
OxyContin maker Purdue Pharma LP and its owners, the Sackler family, are in discussion to settle more than 2,000 lawsuits against the company for $10 billion to $12 billion, two people familiar with the matter said on Tuesday. Purdue is among several drug-makers and distributors ...
While some Johnson & Johnson investors were relieved that the company's $572 million penalty for fueling Oklahoma's opioid epidemic wasn't as high as feared, lawyers for other U.S. states, cities and counties could hardly contain their glee. That's because the ruling by Oklahoma Judge Thad ...
U.S. President Donald Trump's administration on Wednesday announced a plan that would allow the importation of lower-cost prescription drugs from Canada, in a move denounced as "dangerous" by the pharmaceuticals industry. Americans spend an average of $1,200 on prescription drugs per year, according to the ...
Landmark U.S. opioid trial against Johnson & Johnson begins in Oklahoma
The first civil trial that could hold a drug company responsible for the U.S. opioid epidemic began Tuesday in Oklahoma — a case that could affect thousands of others like it. The trial pits the state against Johnson & Johnson. Two other drug companies named ...
